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Abstract  
 Glioblastoma (GBM) is an aggressive incurable brain cancer. The cells that fuel 
the growth of tumours resemble neural stem cells found in the developing and adult 
mammalian forebrain. These are referred to as GBM stem cells (GSCs). Similar to 
neural stem cells, GSCs exhibit a variety of phenotypic states: dormant, quiescent, 
proliferative and differentiating. How environmental cues within the brain influence 
these distinct states is not well understood. Laboratory models of GBM can be 
generated using either genetically engineered mouse models, or via intracranial 
transplantation of cultured tumour initiating cells (mouse or human). Unfortunately, 
these approaches are expensive, time-consuming, low-throughput and ill-suited for 
monitoring of live cell behaviours. Here we explored whole adult brain coronal 
organotypic slices as an alternative model. Mouse adult brain slices remain viable in a 
serum-free basal media for several weeks. GSCs can be easily microinjected into 
specific anatomical sites ex vivo and we demonstrate distinct responses of engrafted 
GSCs to diverse microenvironments in the brain tissue. Within the subependymal 
zone – one of the adult neural stem cell niches – injected tumour cells could 
effectively engraft and respond to endothelial niche signals. Tumour transplanted 
slices were treated with the anti-mitotic drug temozolomide as proof-of-principle of the 
utility in modelling responses to existing treatments. Engraftment of mouse or human 
GSCs onto whole brain coronal organotypic brain slices therefore provides a 
simplified, yet flexible, experimental model. This will help to increase the precision and 
throughput of modelling GSC-host brain interactions and complements ongoing in vivo 
studies. 
  
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
Introduction 
 Glioblastoma multiforme (GBM) is a highly aggressive malignant brain tumour. 
It is the most malignant form of glioma. Standard treatments involve combined 
surgery, radiotherapy, and adjuvant temozolomide (TMZ) chemotherapy (Stupp et al., 
2005), but survival rates are extremely poor. Various obstacles hamper development 
of effective therapies, including: pervasive tumour cell infiltration, genetic 
heterogeneity (both intra- and inter-tumoural), therapeutic resistance, blood-brain 
barrier, and lack of biological understanding of the disease. Improved experimental 
models will help address some of these issues. 
GBM tumour cells disseminate widely across many brain regions, often 
following neuronal tracts and vasculature. Cells are therefore exposed to diverse 
microenvironments, such as specific repertoires of cell matrix and growth factors, or 
cellular niches (e.g. perivascular, invasive or hypoxic). These environmental cues 
steer glioma stem cell (GSC) fate, affecting quiescence, proliferation, survival and 
differentiation pathways (Codrici et al., 2016; Gilbertson and Rich, 2007; Okawa et al., 
2016a). Modelling these various tumour cell-host brain interactions is therefore vital for 
improved understanding of disease biology and development of new therapeutic 
strategies. 
GSCs highjack many molecular programs that regulate neural stem cell self-
renewal. Improved understanding of mechanisms controlling neural stem cell fate will 
therefore likely lead to new insights into the disease and identification of critical 
therapeutic targets. Neural stem cells (NSCs) are located within the lateral walls of the 
forebrain ventricles in a region known as the subependymal zone (SEZ) (Doetsch et 
al., 1999). The SEZ provides a specific niche that sustains the NSCs throughout life. 
NSCs are exposed to a myriad of cell-cell signals and ECM interactions that steer 
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NSC fate, such as: endothelial cells, ependymal cells, and cerebral spinal fluid 
(Mirzadeh et al., 2008; Shen et al., 2008; Silva-Vargas et al., 2016). Understanding 
how tumour cells respond to normal SEZ is important, as this might be region 
harboring a reservoir of tumour cells (Piccirillo et al., 2015). 
Patient-derived GSCs can be routinely expanded in vitro using culture media 
developed for NSCs, either in suspension or adherent culture (Galli et al., 2004; 
Hemmati et al., 2003; Lee et al., 2006; Pollard et al., 2009; Xie et al. 2015). Orthotopic 
transplantation of freshly isolated or cultured GSCs into the adult rodent brain using 
stereotaxic surgery is the ‘gold standard’ method to test tumour-initiating potential. 
However, animal surgery and transplantation deep into the brain provides limited 
scope to track live cell behaviours. Typically, these experiments take weeks or months 
and are non-trivial to setup. They do not enable direct inspection of single cell 
behaviours such as invasion, monitoring of quiescence and differentiation or 
responses to genetic or chemical perturbations. These practical constraints have 
limited the scale and scope of studies aimed at understanding and treating gliomas. 
To address this, we explored the utility of organotypic slice cultures to monitor GSC-
host interactions. 
Organotypic brain slice cultures were first developed in the 1960’s (Crain, 1966). 
Since then they have been widely used by neuroscientists, particularly in studies of 
neuronal function and circuits (reviewed in (Humpel, 2015). Microdissected regions 
are cultured above a semipermeable membrane in a cell culture insert and exposed to 
serum containing media from below. An example of their successful use are studies 
using hippocampal slices cultures; this is widely deployed for studies of synaptic 
plasticity and memory (Gahwiler et al., 1997). Organotypic slice cultures overcome 
some of the difficulties of in vivo studies as they provide ex vivo access to brain tissue 
architecture, while still enabling direct observation and cell manipulations in the culture 
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dish (Humpel, 2015). Slice cultures have also been used to explore the response of 
glioma cells to brain tissue, particularly to explore mechanisms of infiltration and 
migration. However, these have mainly used postnatal brain slices grown in serum or 
of mice harboring preexisting tumours (Minami et al., 2017; Matsumura et al., 2000; 
Jensen et al., 2016; Ohnishi et al., 1998). 
Here, we report improved conditions enabling serum-free culture of adult 
coronal whole brain slices in a manner that enables tracking of GSC behaviors over 
several weeks. Our experimental approach provides a useful new strategy to explore 
GBM. This model bridges the ‘experimental gap’ between in vitro cell culture models 
and in vivo orthotopic transplantations. As an exemplar of the utility of this approach 
we confirm engraftment of GSCs around blood vessels in the slice culture and 
demonstrate how it can be used in preclinical studies of anticancer agents. 
Results 
Whole adult brain coronal slice cultures are viable for weeks in serum-free 
neural stem cell media 
Most studies employing organotypic slice cultures use postnatal mice and 
dissect specific regions of the brain (e.g. hippocampus). However, GBM is 
predominantly a disease of adults and cells disseminate widely across all brain 
regions. We therefore focused on whole brain slices, reasoning that even short-term 
viability, for days or weeks, could provide a useful model for testing tumour cell-host 
brain interactions. 
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 Adult brains were harvested from young adult mice (~4 weeks) and the 
olfactory bulbs and cerebellum were removed (Figure 1A and B). We generated 
whole-brain coronal sections using a vibratome to cut ~200µm slices at the level of the 
forebrain ventricle (6 slices per brain). Each section was placed on to a semi-
permeable membrane culture insert and cultured in a six well cell culture plate (Figure 
1B).  
Established organotypic brain slice protocols require high levels of serum or 
growth factors. However, serum exposure will trigger astrocyte differentiation of NS 
cells (Conti et al., 2005)(Figure S1A-B). Culture media lacking serum or exogenous 
growth factors was therefore tested. This removes the risk of cell fate being primarily 
directed by additives in the culture media, rather than endogenous tissue-derived 
signals. Dying cells were identified at edges of the dissected region, using by 
propidium iodide (PI) staining (Figure 1C) and active Caspase 3 immunostaining 
(Figure 1D).  Serum-free NS cell-permissive culture media could indeed support slices 
over several weeks (Figure 1C). By contrast in basal media with no N2 or B27 
hormonal supplements the tissue became necrotic in days (Figure S1C).  
Within the healthy coronal sections, we were able to detect BIII tubulin-
expressing neuroblasts, gliotubes and choroid plexus, suggesting the tissue retained 
key features of the neurogenic niche (Figure 1E). In summary, whole brain coronal 
slices are viable for several weeks in serum-free media – much longer than we 
anticipated – thereby providing an opportunity to assess responses of transplanted 
GSCs. 
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Patient-derived glioblastoma stem cells engraft into the mouse SEZ and retain 
expression of quiescent NSC markers CD133 and CD9. 
We next tested the potential of patient-derived human GSCs to engraft into the 
slices. G7-GFP cells have previously been shown to be highly invasive when 
transplanted into striatum of immunocompromised mice (Stricker et al., 2013). We 
tested different NS cell markers in vitro before depositing the cells: KI67, OLIG2, 
SOX2, NESTIN, CD9, and CD133 (Figure Supplementary 3A). We first tested 
microinjection of 10000 cells into the SEZ (Figure 2A). One week later using live cell 
imaging we noted large numbers of healthy GFP expressing cells successfully 
engrafted. After 2 weeks, slices were fixed and immunocytochemistry (ICC) confirmed 
cells were viable and ~10% were actively proliferating, based on Ki67 and Stem121 
expression (Figure 2B). We next assessed the known cancer stem cell marker CD133 
in the GFP cells after three weeks. Interestingly, CD133 expressing cells were 
identified in a subset of cells, suggesting that GSCs generate phenotypic 
heterogeneity in the slices (Figure 2C). 
New molecular markers associated with quiescent NSCs have recently been 
uncovered using single cell RNA-seq approaches (Llorens-Bobadilla et al., 2015; Shin 
et al., 2015). The transmembrane glycoprotein tetraspin (CD9) was identified as a 
putative marker of qNSCs. The G7 cells within the SEZ in slices expressed CD9 
(Figure 2D) after 21 days. We conclude that human GSCs can engraft, survive and 
proliferate in whole-brain slice co-cultures for at least 3 weeks, while retaining key 
cancer stem cell markers.  
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 Patient-derived glioblastoma stem cells have distinct responses to region-
specific adult brain microenvironments 
We next compared how cells would respond in the SEZ versus other brain 
regions in terms of their proliferation and differentiation. Four distinct regions were 
tested: striatum, corpus callosum (CC), cortex and SEZ (Figure 3A).  One week after 
microinjection into a lateral region of the CC, we noted many G7 cells aligning with 
and dispersing across the while matter tracts and displaying infiltrative morphology.  PI 
staining of technical replicates was used to assess viability of CC and SEZ adjacent 
regions, and we did not observe any significant cell death in these regions (Figure 
3B). Transplanted cells displayed reduced Ki67 and increased GFAP compared to 
cells deposited in parallel within the SEZ of the same slice (Figure 3C-D). Similar 
results were observed for cells within the cortex and striatum. Thus, slice cultures 
provide a convenient method to quickly assess responses of GSCs to the diverse 
anatomical microenvironments within the adult brain. This enables future exploration 
of various signals regulating cell fate within the SEZ niche.  
Microglia in the adult brain are often activated during injury. In order to check 
whether there was pervasive, and/or region-specific activation of microglia in the 
slices, we assessed the activated microglia marker Ionized calcium binding adaptor 
molecule 1 (Iba1) using immunohistochemistry (Figure 3E). As expected, we noted 
activation; however, this was general at the surface of the slices and was not enriched 
in any specific region. 
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Mouse glioblastoma initiating cells engraft into the subependymal zone and can 
juxtapose to endothelial cells 
To minimize disruption of the niche and to enable injection of smaller 
volumes/numbers of cells (~100 cells in ~40nl) we performed transplantation of cells 
using a microinjection pump connected to a pulled glass capillary (Figure 1A-B). This 
enabled more precise and localized injection into the walls of the lateral ventricle 
(Figure 4A).  We used a previously characterised mouse tumour-initiating cell line, 
termed IENS-GFP (Ink4A/Arf−/− deleted plus EGFRvIII viral overexpression) 
(Bruggeman et al., 2007). These cells stably express GFP from a constitutive 
promoter. In vitro they express GSC markers such as Nestin, Sox2, Olig2 (Figure 
S2A). IENS cells generate aggressive infiltrative tumours when transplanted in vivo  
(n=4) (Figure S2B). These were preferred to human patient-derived G7-GFP, as these 
displayed brighter GFP and were smaller, reducing needle blockage and therefore 
distributing better at the injection site. Moreover, use of mouse glioma cells is 
appealing for future studies, as this enables interrogation of certain immune 
responses (e.g. microglia activation). 
IENS cells were injected precisely into the SEZ through the wall of the lateral 
ventricle. Initially, they displayed a remarkably specific localization and even 
distribution throughout the SEZ (Supplementary Movie 1). We next compared cellular 
responses to the SEZ versus in other brain regions, scoring proliferation and astrocyte 
differentiation or quiescence (type B-like) (Ki67 and GFAP). Four distinct regions were 
tested: cortex, corpus callosum (CC), striatum and SEZ (Figure 4B-4C). As was the 
case with the human transplanted cells, we noted increased proliferation in the SEZ 
(Figure 4B-C). 
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When imaged using confocal microscopy we noted juxtaposition of GSCs with 
endothelial cells (Figure 4E and Supplementary movie 2). The close interactions and 
extended processes along vessels is reminiscent of previous work reporting the 
importance of this as niche for NSCs (Kokovay et al., 2010). 5 days after 
microinjection, the rate of proliferation was around 40-50% (measured as Ki67+ cells 
of the GFP cells). ~15% began to express high levels of the astrocytic marker GFAP 
(Figure 4F). Cells remained viable for two weeks and showed evidence of proliferation 
and local infiltration into surrounding regions (n=3) (Figure 4D and Movie 1 and Movie 
2).  
 
Glioblastoma stem cells engrafted into brain slices respond to the cytostatic 
effects of temozolomide 
Whole brain slices harbouring GSCs provide a convenient method to explore 
the effects of pharmacological agents in an easier and higher throughput experimental 
system than live animals. To demonstrate proof-of-principle of its potential utlity as a 
preclinical assay we first explored anti-mitotic treatments. Ara-C or Temozolomide 
(TMZ) have been widely used to assess neural stem cell behavior during regeneration 
and repair (Daynac et al., 2016; Doetsch et al., 1999). TMZ is the standard 
chemotherapy given to many patients with GBM.  Both agents drive DNA damage and 
disrupt proliferation of tumour cells. TMZ is a DNA alkylating agent that often induces 
G2/M arrest.  
Responses were scored using immunocytochemistry for two markers: gamma-
H2AX for double strand breaks, and p53 as an indicator of DNA damage response 
(Figure 5A). We first tested activity of each factor at previously reported effective 
doses on IENS-GFP cultures in vitro, TMZ at 1,10 and 100µM and AraC at 1 and 2 µM 
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(Figure 5A-B). We next treated slices harbouring successfully engrafted IENS-GFP 
cells after 3 days with 100µM TMZ or 1µM Ara-C (24 hrs). Slices were then assessed 
for Ki67 and pHH3 using immunocytochemistry (Figure 5E-F). In each condition, we 
observed a reduction in Ki67 and GFP double positive cells (100µM TMZ: 13%, 1µM 
Ara-C: 20%). Untreated control slices retained ~30% double positive (Figure 5E-F). To 
determine the degree of cell death by apoptosis following treatment, we scored active 
Caspase 3 (Figure 5G, 5H). Cytostatic responses of tumour cells to drug treatment 
within slice co-cultures can therefore easily be monitored. 
Discussion 
Primary in vitro cell cultures of human glioblastoma stem cells are an important 
disease-relevant experimental model system. However, an obvious limitation of 
dissociated cell cultures is the difficulty in modelling interactions with the complex 
tissue environment. Here we have demonstrated that brain tumour cell interactions 
with host brain tissue can be explored effectively by injection of cells onto adult brain 
slice cultures and co-culture.  
Past studies have typically used microdissected regions of postnatal brain 
slices cultured in the presence of serum, as this is necessary to support long term 
viability (months) (Ullrich et al., 2011). Yet our observations indicate that whole brain 
adult coronal slices are viable in serum free media for several weeks. This is long 
enough to permit tracking of tumour-host tissue interactions, such as interactions with 
endogenous stem cell niches or white matter tracts and enables us to expose GSCs 
to brain tissue interactions. These methods therefore provide a tractable ex vivo 
model system that can now be exploited in both basic and translational studies of 
GBM. It is an approach that reduces the need for laborious and expensive mouse 
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breeding or stereotaxic surgery, thereby increasing the speed and experimental 
throughput. 
Avoiding exposure of transplanted cells to high levels of serum within traditional  
slice cultures methods enables a more physiological signaling environment to be 
maintained. This reduces the degree of serum-induced astrocyte differentiation which 
has hampered our previous studies (unpublished observations). Although serum free 
media has been used to maintain whole-mount tissue explants of the mouse SEZ for 
up to 16 hours (Kokovay et al., 2010), to our knowledge longer term survival of whole 
coronal brain slices in serum free media has not be reported or used in studies of 
GSCs. Surprisingly, we found that serum wasn’t needed in order to maintain healthy 
slices of the whole adult coronal brain, at least for 1 to 2 weeks. Slices seem viable in 
the basal neural media with no exogenous growth factors and supplemented only with 
N2 and B27 hormonal supplements. 
With viable coronal adult brain slices we were able to assess the responses of 
both mouse and human GSCs to distinct anatomical regions over several weeks of co-
culture. As each mouse can provide up to 5 or 6 slices and cells can easily be injected 
in a spatially-restricted manner.  Live cell imaging can be performed to track dynamic 
cell behaviors, such as interactions with blood vessels, infiltration or division 
(Supplementary Movie 1). For example, GBM cells infiltrate widely, and have been 
shown to use both neuronal tracts and blood vessels as a substrate and guide for 
migration (Farin et al., 2006; Krusche et al., 2016). The slice cultures reported here 
should be useful in probing such distinct cellular mechanisms of infiltration. Another 
future potential application will be the tracking of cell lineage reporters, especially with 
the advent of genome editing tools that can be applied in GBM (Bressan et al., 2017). 
This will also help shed light on mechanisms of GSC dormancy and quiescence. One 
limitation of the method is that inevitably we trigger cell death and activation of the 
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microglia through the slicing procedure itself; however, we did not notice region 
specific differences across the slice, and most were located at the cell surface. As the 
slices are relatively thick (~200µm) and tumour cells infiltrate deep into the slice, it 
maybe possible still explore tumour-cell microglia interactions. 
 We were particularly interested in assessing tumour cell responses within the 
SEZ. The SEZ provides a specific niche that sustains the NSCs, and a repertoire of 
cell-cell signals and ECM interactions that steer NSC fate, including: endothelial cells, 
ependymal cells, and cerebral spinal fluid (produced by the choroid plexus) (Mirzadeh 
et al., 2008; Shen et al., 2008; Silva-Vargas et al., 2016). Gliomas may frequently 
arise from endogenous neural stem cells, or serve as a reservoir of cells that in some 
patients can drive relapse (Piccirillo et al., 2015). We noted key elements of the 
healthy SEZ microenvironment were viable – ventricle, gliotubes, RMS, ependymal 
cells. Importantly, endothelial cells within this region are thought to serve as an 
important niche signal; indeed we noted close interactions between vessels and 
tumour cells, with extended processes and wrapping around the vessel, highly 
reminiscent of normal NSC interactions (Kokovay et al., 2010). 
 We demonstrated that human GSCs can engraft effectively into the tissue of 
SEZ. CD133 is expressed by many glioma stem cells. We observed expression of this 
marker in both the mouse and human GSCs. Another more recently proposed marker 
of the quiescent astrocytes is CD9. We and others have recently found increased 
levels of CD9 in GSCs compared to normal NSCs (Okawa et al., 2016b; Podergajs et 
al., 2015). We found that CD9 is indeed retained on cells within the SEZ, suggesting 
‘stemness’ may be effectively retained. As anticipated, reduced proliferative 
responses were noted when cells were deposited at other anatomical sites, such as 
corpus callosum. Distinct brain regions clearly will have significant differences in their 
ability to influence tumour cell proliferation and differentiation.  
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A limitation of this slice culture approach is the difficulty of achieving viable slice 
cultures past 3 weeks.  Although we did note some loss of some tissue integrity past 
three weeks, we did not specifically push this further or search for modified culture 
regimes. This might be important to resolve in future, particularly for slower growing 
human GSCs, which take weeks to months to start initiate tumour growth in live 
xenografted mice. This alongside the damage and immune activation triggered by the 
slice procedure itself and inherent disadvantages that means this assay cannot 
replace either GEMMs or intracranial transplantation in live mice. 
A multitude of new agents are emerging that will require effective preclinical 
studies. There is bottleneck and huge cost associated with testing of new 
pharmacological agents in living animals before these can enter clinical trials for GBM.  
The methods outlined here offer a potential complementary assay to in vivo testing. 
To demonstrate potential utility as preclinical model, we tested the responses of cells 
to antimitotics (AraC and TMZ). TMZ is used in many GBM, yet our understanding of 
how it influences distinct compartments of the GSC and resistance mechanisms 
remains limited. Future candidate drugs will need to be explored alongside TMZ to 
search for the most effective doses and regimes. Thus, the methods reported here 
should therefore prove useful in prioritsing and triage of candidate therapeutic agents 
moving through preclinical studies. 
In conclusion, the organotypic method presented here provides a simplified 
model for assessing responses of GSCs to various brain anatomical sites and 
microenvironments. This will therefore complement existing in vitro and in vivo 
models, helping to prioritise genes and pathways controlling key malignant properties 
of GBM and aiding the preclinical testing of new anti-cancer agents. 
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 Materials and Methods 
Organotypic adult brain slice culture.  
5-8 week old C57BL/6 mice were used. More consistent results were often 
obtained using the younger animals – particularly the viability after 2-3 weeks culture. 
The brain was removed from the skull and transferred to a 10cm2 tissue culture dish 
with sterile PBS and placed on ice (Figure1A-1B). Cerebellum and olfactory bulb were 
removed (Figure 1B) and remaining forebrain transferred into a 35mm2 dish with pre-
warmed 3% SeaPlaque™ agarose (50100 Lonza) (Figure 1A-1B). Upon cooling in ice 
the block was removed and cut using a scalpel into a ~ 2cm cube around the brain. 
Before starting to cut a 6 well plate was prepared: in each well we introduced one cell 
culture insert (PICMORG50 Millicell) and added bellow it 1mL of culture media in 
serum-free basal NS cell media, DMEM:F12 supplemented with N2 and B27 (Life 
Technologies). The embedded brain was placed in the circular vibratome plate with 
glue (Figure 1A-1B). The vibratome (Leica VT1000 S) plate was fixed in the platform 
and was filled with PBS with penicillin-streptomycin (Gibco 15140-122 1:100). 250 µm 
thick slices were cut, with vibrating frequency at 8 and speed to 3. Each slice was 
transferred using a small brush onto the top of a Millipore culture insert (Figure 1A-
1B). Six slices were cut per animal along the SEZ. The platform has to be maintained 
cooled all the time. We obtained six slices around the forebrain ventricle. The 6 well 
plate was placed in an incubator at 37ºC + 5% CO2. Incubate slices 24-48 hours prior 
to cell transplantation. 
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 Glioblastoma cancer stem cell transplantation onto brain slices 
G7 human GBM stem cell cultures have been previously described (Stricker et 
al., 2013). For human cell transplants a standard Gilson pipette was used to deposit 
0.2 µl of cells onto the centre of the striatum, the typical injection site when performing 
stereotaxic surgery for tumour initiation assays. These cells engrafted well into the 
slice and their integration could be observed the following day. 
IENS-GFP mouse cells were a gift from Dr. Lohuizen (Bruggeman et al., 2007). Both 
mouse and human GNS cells were grown using conditions previously described 
(Pollard et al., 2009). After centrifugation cells were harvested and resuspended in 
media at 100,000 cells/µl. Cells were used immediately for transplantation in the SEZ. 
Two different methods of cells injection were used. A manual using a p2 Gilson pipette 
was used to injected 0.5ul, while an auto-nanoliter injector (Nanoject II, Drummond 
Scientific Company) was used for 40-100nl injections.  For the injector we use glass 
capillaries pulled using an automated needle puller (tip diameter, 10–20 μm; 
Drummond) (Figure 1B). 4000 cells were transplanted per injection. 20000 cells were 
transplanted when the P2 pipette was used. To facilitate engraftment and prevent 
wide dispersion of the 0.2 µl of cells, we used forceps to make a small indentation in 
the transplant site prior to delivery of the cells. Slices with cells were incubated at 
37ºC + 5% CO2  for 7 days, with fresh NS cell media (no EGF or FGF-2) added every 
2 days. Cell engraftment of the cells was observed 4 days after transplantation and 
cells could were monitored using a fluorescence stereo microscope (Leica M165 FC). 
For anti-mitotic treatments in the IENS-GFP in vitro, different doses of the cytosine 
arabinoside (AraC) (Sigma) was added to the complete media at different doses 1µM, 
2uM and TMZ (Sigma) at 1uM, 10uM and 100uM for 24 hours.  For anti-mitotic 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
treatments of IENS-GFP in the slices, the cells were growing in the brain slice for 3 
days and the AraC was added to the complete media at different doses at 1µM and 
TMZ at 100µM for 24 hours.  
 
 
Immunocytochemistry 
Media was removed and exchanged for 1mL of freshly prepare 4% paraformaldehyde 
(PFA). 1-2 mL was also placed gently on top to cover the slice. After for 2 hours PFA 
was removed and brain slices were wash with PBS three times. Slices were transfer 
using a brush to a 24 well plate.  Slices were incubated at room temperature 1 hour 
and a half in blocking solution (0.2% Triton X-100 and 3% Goat Serum; Sigma). 
Primary antibodies GFAP (G3893 Sigma 1:100), Ki-67 (RM-9106 Thermo Fisher 
1:100), GFP (13970 Abcam 1:100), CD31 (14-0311-81 eBiosience 1:100), CD9 (14-
0091-82, eBioscience 1:500), CD133 (MAB4310, Millipore 1:100), DCX (AB2253 
Millipore 1:500), Nestin (1/10 Hybridoma Rat 401), stem121 (440410, Cellalartis 
1:300), pH3 (50-9124-41, eBioscience 1:50), H2AX (phosphor S139)  (ab81299, 
Abcam 1:50), Iba1 (NB-1-1028SS Novus 1:100), Olig2 (AB9610 Millipore 1:200), Sox2 
(AB5603 Millipore 1:100), active 3 Caspase (ab2302 Abcam 1:100). 
For H2AX staining cells were fixed with could fix the cells methanol-acetone 1:1 for 10 
min run temperature. Positive cells were scored using the Fiji image analysis software. 
For IHC, the primary antibodies were incubated 2 days at 4ºC. After three washes with 
PBS, slices were incubated with with appropriate Alexa Fluor (Life technologies) 
secondary antibody and DAPI (D9542-SIGMA) with for 4-6 hours. Slices were washed 
three times and were mounting in a slide and immersed in FluoroSaveTM Reagent 
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(345789 Calbiochem). Slices were examined with a confocal microscope (Leica TCS 
SP8). Propidium iodide (14289-25 CAYMAN) was used at 5ug/ml in PBS for 5 min 
and the tissue was analyzed under the fluorescent steromicroscope. For Hematoxylin 
and eosin staining brain slices were fixed with 4% PFA for 1 hour. They were 
immersed in Harris Hematoxylin (Thermo-6765004) for 10 min and after washed in tap 
water. Following this, the slices were immersed 10 sec in 1% Acid –Alcohol and 
washed again in tap water.  The brain slices were in tap water 30 sec and washed 
again in tap water. Finally, they were immersed in Eosin Y (Thermo-6766010) for 10s 
and washed once more. The brain slices were imaged using Leica steromicroscope. 
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Figures 
 
 
Figure 1 | Overall experimental strategy and tissue processing. (A) Summary of 
experimental procedure to generate slices. (B) Experimental steps in the harvesting, 
mounting, slicing and injection of brain tissue; (a) scissors, forceps and spatula are 
used to isolate and dissect the whole brain; (b) Image of whole adult mice brain on ice 
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following harvesting; (c) Dorsal image of whole brain following removal of the olfactory 
bulb (OB) and cerebellum; (d) Embedded brain in low melting agarose; (e) Attached 
brain to the support of the vibratome; (f) ~250µm coronal brain slice of placed onto a 
cell culture insert in a 6 well plate with neural stem cell basal media; (g) nanoinjector 
mounted on a micromanipulator used for injection of small volumes of cells, with 
mounted glass capillary (h), containing cell suspension; and (i) microinjection of cells 
into the SEZ of a coronal brain slice on the cell culture insert. (C) Top panel, viability of 
the tissue assessed using propidium iodide (PI) after 7, 14 and 21 days. Bottom panel, 
active-caspase 3 staining. Quantification of the mean intensity of the PI in the brain 
slices up to 21 days (right). (D) Immunocytochemistry following 7 days slice co-culture 
for: GFAP positive gliotubes (green left panel); B III tubulin neuroblasts (red middle 
panel) and choroid plexus (H&E; right). Nuclear counterstaining with DAPI in each 
(blue). SEZ: subependymal zone; CC, corpus callosum; LV; lateral ventricle, Sep: 
Septum. RMS; Rostral migratory stream. Scale bars: 100µm (left) and 10µm (right). 
N=3, Students t-test p < 0.05. 
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 Figure 2 | Human patient-derived glioma stem cells engraft in adult mouse 
subependymal zone. (A) Direct microinjection of human line into adult SEZ and 
visualisation of engrafted live cells using a constitutive GFP reporter. Right panels are 
zoom of left panels. (B) Immunostaining for human specific cytoplasmic antigen 
(Stem121; yellow) and Ki67 (red) after 14 days. (C and D), Marker analysis after 21 
days of ex vivo culture; (C) immunocytochemistry for CD133 (purple);  (D) CD9 (red). 
Nuclear counterstaining with DAPI (blue). Scale bars: B = 50 µm and C,D = 20 µm. 
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Figure 3 | Differential proliferative responses to human glioma stem cells 
engrafted into different brain regions 
(A) Live images of G7-GFP human glioma stem cells deposited into distinct regions of 
the same coronal brain slice after 7 days. (B) Immunocytochemistry for GFAP (yellow) 
and Ki67 (red) and GFP (green). CC: corpus callosum. (C) Quantification of the 
percentage of proliferating and differentiating cells (Ki67 and GFAP, respectively). (D) 
Inmunocytochemistry for Iba1 (green) in different brain regions: CC, Cortex, Striatum, 
SEZ. Scale bars: B,D= 50 µm. N=3, Students t-test p<0.01. 
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 Figure 4 | Glioma stem cells (GSC) in their niche. (A) (Left) Schematic of the 
experimental setup: co-culture of the GSC and the whole brain coronal sections. 
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Right, panoramic position of the GSC (green) in the SEZ after deposition. (B) 3D 
image showing the engraftment and infiltration of the IENS-GFP in the brain slice after 
5 days. (C) 3D image with inmunostaining of the IENS-GFP contacting with the blood 
vessels. GFP (green), CD31 (red) and nuclear counterstaining with DAPI (blue). 
Schematics of the interaction GSC with brain blood vessels. (D) Top panel: Panoramic 
view of IENS-GFP cells in SEZ. Immunostaining for GFP (green), Ki67 (white), GFAP 
(purple) and nuclear counterstaining with DAPI (blue). Bottom panel: Detail of the top 
one. Cells proliferating and expressing some GSC and astrocytic marker as GFAP 
and the proliferative marker Ki67. (E) Immunostaining for GFAP (yellow), Ki67 (red) 
and GFP (green) in the cells deposited in different parts of the brain slices. (F) 
Quantification of the percentage of GFAP and Ki67. In (C) cx, cortex; cc, corpus 
callosum; st, striatum; SEZ, subependymal zone; LV, lateral ventricle. Scale in (B) 
20µm, (F) 20µm (G) 50µm (E) 100 µm. N=3, Students t-test p<0.01. 
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Figure 5 | Temozolomide and Ara-C treatment of slice co-cultures. (A) DNA 
damage responses of mouse IENS-GFP cells following treatment various does of 
antimitotic agents AraC and TMZ. Immunocytochemistry for H2AX (yellow) and p53 
(red). Nuclear counterstaining DAPI (blue) (B) Quantitation of mean intensity of the 
nuclear H2AX foci (arbitrary units). Schematics of the co-culture of IENS-GFP cells in 
the brain slices adding pharmacological inhibitors of the proliferation. (D) 
Inmunostaining for GFP (green) and Ki67 (magenta) with DAPI (blue) for nuclear 
counterstaining (E) Quantification of the percentage of Ki67 (proliferative cells) using 
the proliferative inhibitors in IENS-GFP after 24 hours. (F) Inmunocytochemistry for 
GFP (green) and pHH3 (mitotic cells) (red) in IENS-GFP after treatments. Percentage 
of pHH3 positive cells are in red typing. Scale bars 20µm. (G). Quantification of 
percentage of active caspase3 in the IENS-GFP cells after the treatments with AraC 
and TMZ. (H) Immunostaining for active caspase3 in the IENS-GFP cells in the brain 
slices after treatments. Scale bars in (A) 10 µm, (D), (F), (H) 30 µm. N=3, Students t-
test p<0.01 in E and N=3, Students t-test p < 0.05. 
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Supplementary Figure 1. (A) Immunostaining for GFAP (red) and Ki67 (magenta) of 
IENS-GFP cells deposited in the brain slices with complete media with/without serum. 
(B) Quantification of the percentage of cells positive for GFAP and KI67. (C) PI 
staining in brain slices after 24 hours. Slices were cultured with DMEM-F12 or with 
complete media. Scale bar in A: 30 µm. N=3, Students t-test p<0.01. 
Disease Models & Mechanisms 10: doi:10.1242/dmm.031435: Supplementary information
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Supplementary Figure 2. IENS-GFP cells on the brain tissue in complete media or 
complete media supplemented with serum after 5 days (A) Immunostaining of GFAP 
(red) and KI67 (magenta) in IENS-GFP. (B) Quantification of the percentage of KI67 
and GFAP positive cells. Scale bar in A: 20 µm.  
Disease Models & Mechanisms 10: doi:10.1242/dmm.031435: Supplementary information
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Supplementary Figure 3. (A) G7cells in vitro.  Immunostaining for different markers 
in vitro. KI67 (red), Olig2 (red), Sox2 (red), Nestin (yellow), CD9 (red), CD133 (red). 
Scale bar:  A= 20 µm 
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